Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (121-130 of 381) with videos related to

Pageof 39
Sort By:
Rheumatology International|February 6, 2024
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patientsMateusz Wilk, Brigitte Michelsen, Katarzyna Łosińska, et al.
The Journal of Rheumatology|October 11, 2002
Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosusMeena Shah, Arthur Kavanaugh, Yvonne Coyle, et al.
Plos One|May 5, 2022
Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard careBrigitte Michelsen, Kristine Thomassen Berget, Jon Håvard Loge, et al.
Rheumatology (Oxford, England)|November 25, 2010
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritisSanna Rosengren, Nathan Wei, Kenneth C Kalunian, et al.
American Journal of Clinical Dermatology|January 1, 2016
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyMark G Lebwohl, Arthur Kavanaugh, April W Armstrong, et al.
Rheumatology (Oxford, England)|December 20, 2011
Working at arthritisPeter Short, Adrian C Jones, David Walker, et al.
Annals of the Rheumatic Diseases|August 22, 2013
Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag health study (HUNT)Mari Hoff, Agnete Malm Gulati, Pål Richard Romundstad, et al.
Arthritis and Rheumatism|September 6, 2005
Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agentsZuhre Tutuncu, Arthur Kavanaugh, Nathan Zvaifler, et al.
Cureus|December 24, 2025
Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort StudyRoel Sanchez Baez, Arthur Kavanaugh, Monica Guma, et al.
Arthritis Research & Therapy|February 5, 2020
Assessing structural damage progression in psoriatic arthritis and its role as an outcome in researchDésirée van der Heijde, Dafna D Gladman, Arthur Kavanaugh, et al.
Pageof 39

Showing results (121-130 of 381) with videos related to

Sort By:
Pageof 39
Rheumatology International|February 6, 2024
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patientsMateusz Wilk, Brigitte Michelsen, Katarzyna Łosińska, et al.
The Journal of Rheumatology|October 11, 2002
Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosusMeena Shah, Arthur Kavanaugh, Yvonne Coyle, et al.
Plos One|May 5, 2022
Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard careBrigitte Michelsen, Kristine Thomassen Berget, Jon Håvard Loge, et al.
Rheumatology (Oxford, England)|November 25, 2010
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritisSanna Rosengren, Nathan Wei, Kenneth C Kalunian, et al.
American Journal of Clinical Dermatology|January 1, 2016
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyMark G Lebwohl, Arthur Kavanaugh, April W Armstrong, et al.
Rheumatology (Oxford, England)|December 20, 2011
Working at arthritisPeter Short, Adrian C Jones, David Walker, et al.
Annals of the Rheumatic Diseases|August 22, 2013
Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag health study (HUNT)Mari Hoff, Agnete Malm Gulati, Pål Richard Romundstad, et al.
Arthritis and Rheumatism|September 6, 2005
Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agentsZuhre Tutuncu, Arthur Kavanaugh, Nathan Zvaifler, et al.
Cureus|December 24, 2025
Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort StudyRoel Sanchez Baez, Arthur Kavanaugh, Monica Guma, et al.
Arthritis Research & Therapy|February 5, 2020
Assessing structural damage progression in psoriatic arthritis and its role as an outcome in researchDésirée van der Heijde, Dafna D Gladman, Arthur Kavanaugh, et al.
Pageof 39